2.00
Seer Inc stock is traded at $2.00, with a volume of 421.31K.
It is up +1.01% in the last 24 hours and down -7.41% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$1.98
Open:
$1.99
24h Volume:
421.31K
Relative Volume:
3.22
Market Cap:
$104.59M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.5385
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
-3.85%
1M Performance:
-7.41%
6M Performance:
-3.38%
1Y Performance:
-12.28%
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SEER
Seer Inc
|
2.00 | 110.46M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.03 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.75 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.76 | 61.08B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
914.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.56 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Can Seer Inc. stock sustain market leadershipVolume Spike & Daily Growth Stock Tips - newser.com
What insider trading reveals about Seer Inc. stockMarket Activity Report & Reliable Volume Spike Alerts - newser.com
How Seer Inc. stock performs in stagflationGDP Growth & Weekly Market Pulse Alerts - newser.com
Should I hold or sell Seer Inc. stock in 2025Earnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Does Seer Inc. stock trade at a discount to peersWeekly Profit Report & High Return Trade Guides - newser.com
Why Seer Inc. stock is rated strong buy2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Volatility clustering patterns for Seer Inc.2025 Support & Resistance & Free Technical Pattern Based Buy Signals - newser.com
How to forecast Seer Inc. trends using time series2025 Pullback Review & AI Driven Price Forecasts - newser.com
Why Seer Inc. stock is seen as undervaluedAnalyst Upgrade & Technical Pattern Based Signals - newser.com
How to manage a losing position in Seer Inc.Market Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Is Seer Inc. stock a smart buy before Fed meetingProfit Target & Fast Gain Swing Trade Alerts - newser.com
Is Seer Inc. trending in predictive chart models2025 Short Interest & High Return Trade Guides - newser.com
Custom strategy builders for tracking Seer Inc.2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com
Key metrics from Seer Inc.’s quarterly dataDip Buying & Fast Momentum Stock Entry Tips - newser.com
What drives Seer Inc stock pricePrice Gap Trading Strategies & AI-Based Insights for Consistent Profits - earlytimes.in
Seer, Inc. Earnings Call: Achievements Amid Challenges - TipRanks
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):